Detalhe da pesquisa
1.
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
Curr Oncol Rep
; 22(5): 47, 2020 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297022
2.
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
Curr Oncol Rep
; 22(2): 19, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030483
3.
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.
Neuro Oncol
; 25(1): 54-67, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605606
4.
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
Elife
; 112022 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35311647
5.
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization.
Cell Rep
; 38(2): 110216, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35021084
6.
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.
Neuro Oncol
; 24(8): 1366-1374, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137228
7.
Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma.
Clin Cancer Res
; 26(15): 4080-4092, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32332014
8.
Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India.
Ocul Surf
; 17(1): 50-54, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30157458
9.
Progression of keratoconus resulting from hormone replacement therapy.
J Cataract Refract Surg
; 45(7): 1055, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31262478